Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Accompanying Editorial

Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
© 2016 American Academy of Neurology.

Files in this Data Supplement: